semaglutide and pre-existing conditions Side Effects: What Patients Should Know in 2025 Semaglutide as a GLP-1 Agonist:

These include: Major depressive disorder (MDD) Panic disorder (PD) Social anxiety disorder (SAD) Post-traumatic stress disorder (PTSD) Obsessive-compulsive disorder (OCD) Premenstrual dysphoric disorder (PMDD) Both medications can also be used to treat some conditions off-label

Tirzepatide may be helpful for some patients who are dealing with weight gain, insulin resistance, blood sugar concerns, or weight-related cardiovascular risk factors

In 2009, EMA approved liraglutide for treatment of type 2 diabetes (T2D), followed by the approval of semaglutide for T2D treatment in 2018

It's a supplement that supports your body's essential functions and helps you thrive